NCT05923060 2026-02-20
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
24 trialsNCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT06712381 2024-12-02
Carac & PDT Combination in the Treatment Of Actinic Keratoses
Skin Laser & Surgery Specialists
Phase 1/2 Completed
NCT03467789 2024-10-17
Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00472108 2024-08-05
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma
Galderma R&D
Phase 3 Completed
NCT01966120 2023-07-28
Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT00784108 2022-11-01
Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.
University of California, Irvine
Phase 1 Completed
NCT04140292 2022-06-24
Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00558688 2021-12-06
A Photodynamic Therapy for Treatment of Actinic Keratoses
Northwestern University
Phase NA Completed
NCT00306800 2021-02-18
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
Galderma R&D
Phase 3 Completed
NCT02157623 2020-07-30
Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
The Cleveland Clinic
Phase NA Completed
NCT01800838 2019-05-16
Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma
Case Comprehensive Cancer Center
Phase 1 Completed
NCT02628236 2017-09-18
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT02281136 2017-01-13
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT01292668 2014-09-29
Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT01541228 2013-09-04
Photodynamic Treatment of Actinic Keratoses With Different Light Doses
Lithuanian University of Health Sciences
Phase NA Completed
NCT00926952 2011-09-09
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Innovaderm Research Inc.
Phase 3 Completed
NCT00711178 2010-11-02
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)
Bispebjerg Hospital
Phase NA Completed
NCT00985829 2009-12-22
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
Shahid Beheshti University of Medical Sciences
Phase 1 Completed
NCT01015898 2009-11-18
Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma
Shahid Beheshti University of Medical Sciences
Phase 1 Completed
NCT00988455 2009-10-02
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up
Shahid Beheshti University of Medical Sciences
Phase 1/2 Completed
NCT00308854 2008-04-11
Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK
photonamic GmbH & Co. KG
Phase 3 Completed
NCT00308867 2008-04-11
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
photonamic GmbH & Co. KG
Phase 3 Completed
NCT00432224 2007-02-07
Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light
Bispebjerg Hospital
Phase NA Completed